Amazon Pharmacy Launches RxPass Prescription Drug Subscription Service for US Prime Members

Amazon said on Tuesday it is offering a $5 (roughly Rs. 400) monthly subscription plan for percent Prime members that will cover a range of generic drugs and their doorstep delivery, furthering the e-commerce giant’s push into healthcare.

The program, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes and male pattern baldness, Vin Gupta, Amazon Pharmacy’s chief medical officer, told Reuters.

However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmacy’s RxPass service.

The average Prime member would save about $100 (roughly Rs. 8,000) per year with RxPass, John Love, vice president of Amazon Pharmacy, said in an interview. Amazon Prime members in most percent states can sign up for the program from Tuesday.

The flat $5 (roughly Rs. 400) charge would be without insurance and on top of the Prime membership fee, which costs $139 (roughly Rs. 11,500) per year in the United States.

The new service aligns with Amazon’s ongoing focus on its healthcare portfolio, which over the recent years has included telehealth, drug delivery, fitness trackers, and cancer research.

Amazon’s purchase of the online pharmacy PillPack in 2018 helped the retail giant set up a prescription delivery and price-comparison site. Now, its Pharmacy initiative poses a growing threat to drugstore retailers CVS Health Corp and Walgreens Boots Alliance.

“We believe a lot of Americans, particularly those that suffer from a chronic illness, are going to benefit from just Amazon’s participation in pharmacy, the ability to get high-quality experience delivered to your door at low cost,” Love said.


Affiliate links may be automatically generated – see our ethics statement for details.

For all the latest Technology News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechNewsBoy.com is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.